Resources | Avammune

News

Healthtech Startup Avammune Bags $12 Mn From Capital 2B, Others

Publications

AVA-NP-695 Selectively Inhibits ENPP1 to Activate STING Pathway and Abrogate Tumor Metastasis in 4T1 Breast Cancer Syngeneic Mouse Model.

Avijit Goswami, Barnali Deb, Sandeep Goyal, Abhishek Gosavi, Mukund Mali, Ashwita M. Martis, Princy Khurana, Mukesh Gangar, Digambar Raykar, Ankita Mohanty and Aditya Kulkarni

Molecules. October 2022, 27, 6721

Design, synthesis and biological evaluation studies of novel small molecule ENPP1 inhibitors for cancer immunotherapy.

Mukesh Gangar, Sandeep Goyal, Digambar Raykar, Princy Khurana, Ashwita M. Martis, Avijit Goswami, Ishani Ghoshal, Ketul V. Patel, Yadav Nagare, Santosh Raikar, Apurba Mukherjee, Rajath Cyriac, Jean-François Paquin, Aditya Kulkarni

Conference Abstracts

Abstract 6898: Identification of a novel first-in-class inhibitor targeting the ADAR1 p150 isoform demonstrates robust anti-tumor efficacy in a syngeneic mouse model

Avijit Goswami, Sandeep Goyal, Kawaljit Singh, Princy Khurana, Aditya Kulkarni

Journal: Cancer Research Cancer Res (2025) 85 (8_Supplement_1): 6898. https://doi.org/10.1158/1538-7445.AM2025-6898

Abstract 652: Exploring the therapeutic benefit of AVA-NP-695 with combination modalities in ICB refractory and rare cancers

Borja Ruiz-Fernandez de Cordoba, Avijit Goswami, Sandeep Goyal, Kawaljit Singh, Princy Khurana, Alejandro Sweet-Cordero, Aditya Kulkarni

Journal: Cancer Research Cancer Res (2025) 85 (8_Supplement_1): 652. https://doi.org/10.1158/1538-7445.AM2025-652

News

Publications

Conference Abstracts

Reach out to us

→

USA

India